PBS Subsidies in Australia Will Lower Cost of Kesimpta & Why You Matter to the MS Community episode artwork

EPISODE · Jan 5, 2022 · 8 MIN

PBS Subsidies in Australia Will Lower Cost of Kesimpta & Why You Matter to the MS Community

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how people in Australia with multiple sclerosis (MS) and certain other medical conditions will have access to new and expanded medications — including Kesimpta — now listed on the Pharmaceutical Benefits Scheme (PBS).Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Celebrity or Not, You Matter to the MS Community”.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Jan 5, 2022

Embed this episode

NOW PLAYING

PBS Subsidies in Australia Will Lower Cost of Kesimpta & Why You Matter to the MS Community

0:00 8:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 8 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on January 5, 2022.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!